Literature DB >> 16988005

Macaque multimeric soluble CD40 ligand and GITR ligand constructs are immunostimulatory molecules in vitro.

Geoffrey W Stone1, Suzanne Barzee, Victoria Snarsky, Celsa A Spina, Jeffrey D Lifson, Vinod Kumar Bhaskara Pillai, Rama Rao Amara, François Villinger, Richard S Kornbluth.   

Abstract

CD40 ligand (CD40L) and GITR ligand (glucocorticoid-induced tumor necrosis factor receptor-related protein ligand [GITRL]) are tumor necrosis factor superfamily molecules that can be used as vaccine adjuvants. In a previous human immunodeficiency virus (HIV) DNA vaccine study in mice, we found that plasmids expressing multimeric soluble forms of trimeric CD40L (i.e., many trimers) were stronger activators of CD8(+) T-cell responses than were single-trimer soluble forms or the natural membrane-bound molecule. This report describes similar multimeric soluble molecules that were constructed for studies in macaques. Both two-trimer and four-trimer forms of macaque CD40L were active in B-cell proliferation assays using macaque and human cells. With human cells, four-trimer macaque GITRL costimulated CD4(+) T-cell proliferation and abrogated the immunosuppressive effects of CD4(+) CD25(+) regulatory T cells on a mixed leukocyte reaction. These molecular adjuvants provide new tools for vaccine development in the simian immunodeficiency virus system and other macaque models.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16988005      PMCID: PMC1656546          DOI: 10.1128/CVI.00198-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  41 in total

1.  IL-7 stimulates T cell renewal without increasing viral replication in simian immunodeficiency virus-infected macaques.

Authors:  Marie-Thérèse Nugeyre; Valérie Monceaux; Stéphanie Beq; Marie-Christine Cumont; Raphaël Ho Tsong Fang; Laurent Chêne; Michel Morre; Françoise Barré-Sinoussi; Bruno Hurtrel; Nicole Israël
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

Review 2.  CD40/CD154 interactions at the interface of tolerance and immunity.

Authors:  Sergio A Quezada; Lamis Z Jarvinen; Evan F Lind; Randolph J Noelle
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

3.  Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets.

Authors:  Katharina M Huster; Verena Busch; Matthias Schiemann; Kathrin Linkemann; Kristen M Kerksiek; Hermann Wagner; Dirk H Busch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-25       Impact factor: 11.205

4.  Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity.

Authors:  Christopher M Smith; Nicholas S Wilson; Jason Waithman; Jose A Villadangos; Francis R Carbone; William R Heath; Gabrielle T Belz
Journal:  Nat Immunol       Date:  2004-10-10       Impact factor: 25.606

Review 5.  DNA vaccines against human immunodeficiency virus type 1 in the past decade.

Authors:  Malavika Giri; Kenneth E Ugen; David B Weiner
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

6.  Purification, characterization and cDNA cloning of human lung surfactant protein D.

Authors:  J Lu; A C Willis; K B Reid
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

7.  Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells.

Authors:  Masahide Tone; Yukiko Tone; Elizabeth Adams; Stephen F Yates; Mark R Frewin; Stephen P Cobbold; Herman Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-07       Impact factor: 11.205

8.  Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells.

Authors:  Fumiko Kanamaru; Pornpan Youngnak; Masaaki Hashiguchi; Tomohisa Nishioka; Takeshi Takahashi; Shimon Sakaguchi; Isao Ishikawa; Miyuki Azuma
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

Review 9.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

Authors:  Shimon Sakaguchi
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

10.  Cloning and characterization of GITR ligand.

Authors:  J D Kim; B K Choi; J S Bae; U H Lee; I S Han; H W Lee; B S Youn; D S Vinay; B S Kwon
Journal:  Genes Immun       Date:  2003-12       Impact factor: 2.676

View more
  16 in total

1.  Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.

Authors:  Saravana K Kanagavelu; Victoria Snarsky; James M Termini; Sachin Gupta; Suzanne Barzee; Jacqueline A Wright; Wasif N Khan; Richard S Kornbluth; Geoffrey W Stone
Journal:  Vaccine       Date:  2011-12-04       Impact factor: 3.641

Review 2.  Technologies for enhanced efficacy of DNA vaccines.

Authors:  Fadi Saade; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

3.  Expression and purification of soluble murine CD40L monomers and polymers in yeast Pichia pastoris.

Authors:  Christina E Hermanrud; Carrie L Lucas; Megan Sykes; Christene A Huang; Zhirui Wang
Journal:  Protein Expr Purif       Date:  2010-11-11       Impact factor: 1.650

Review 4.  Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".

Authors:  Kimberly A Schoenly; David B Weiner
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

5.  DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.

Authors:  Sachin Gupta; Emily S Clark; James M Termini; Justin Boucher; Saravana Kanagavelu; Celia C LeBranche; Sakhi Abraham; David C Montefiori; Wasif N Khan; Geoffrey W Stone
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

Review 6.  Design of CD40 agonists and their use in growing B cells for cancer immunotherapy.

Authors:  Richard S Kornbluth; Mariusz Stempniak; Geoffrey W Stone
Journal:  Int Rev Immunol       Date:  2012-08       Impact factor: 5.311

Review 7.  Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.

Authors:  Giuseppe Nocentini; Simona Ronchetti; Maria Grazia Petrillo; Carlo Riccardi
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 8.  Design of vaccine adjuvants incorporating TNF superfamily ligands and TNF superfamily molecular mimics.

Authors:  Sachin Gupta; James M Termini; Saravana Kanagavelu; Geoffrey W Stone
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

9.  A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model.

Authors:  Sachin Gupta; James M Termini; Yaelis Rivas; Miguel Otero; Francesca N Raffa; Vikas Bhat; Amjad Farooq; Geoffrey W Stone
Journal:  Vaccine       Date:  2015-08-01       Impact factor: 3.641

10.  Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma.

Authors:  Geoffrey W Stone; Suzanne Barzee; Victoria Snarsky; Camila Santucci; Brian Tran; Robert Langer; Gregory T Zugates; Daniel G Anderson; Richard S Kornbluth
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.